Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Vaughan

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
JAMA|September 28, 1994
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activatorP M Ridker, D E Vaughan, M J Stampfer, et al.
Lancet (London, England)|April 16, 1994
Prospective study of endogenous tissue plasminogen activator and risk of strokeP M Ridker, C H Hennekens, M J Stampfer, et al.
Lancet (London, England)|May 8, 1993
Endogenous tissue-type plasminogen activator and risk of myocardial infarctionP M Ridker, D E Vaughan, M J Stampfer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1993
A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100P M Ridker, D E Vaughan, M J Stampfer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged menP M Ridker, M T Baker, C H Hennekens, et al.
Analytical Biochemistry|April 26, 2001
Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assayL J Murphey, D L Hachey, D E Vaughan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigenN J Brown, L J Murphey, N Srikuma, et al.
Circulation|August 15, 2001
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibitionK Kaikita, A B Fogo, L Ma, et al.
Biochimica Et Biophysica Acta|October 6, 1993
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1)D E Vaughan, P J Declerck, T M Reilly, et al.
The American Journal of Physiology|December 9, 1998
Liver regeneration is transiently impaired in urokinase-deficient miceH T Roselli, M Su, K Washington, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
JAMA|September 28, 1994
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activatorP M Ridker, D E Vaughan, M J Stampfer, et al.
Lancet (London, England)|April 16, 1994
Prospective study of endogenous tissue plasminogen activator and risk of strokeP M Ridker, C H Hennekens, M J Stampfer, et al.
Lancet (London, England)|May 8, 1993
Endogenous tissue-type plasminogen activator and risk of myocardial infarctionP M Ridker, D E Vaughan, M J Stampfer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1993
A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100P M Ridker, D E Vaughan, M J Stampfer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged menP M Ridker, M T Baker, C H Hennekens, et al.
Analytical Biochemistry|April 26, 2001
Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assayL J Murphey, D L Hachey, D E Vaughan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigenN J Brown, L J Murphey, N Srikuma, et al.
Circulation|August 15, 2001
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibitionK Kaikita, A B Fogo, L Ma, et al.
Biochimica Et Biophysica Acta|October 6, 1993
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1)D E Vaughan, P J Declerck, T M Reilly, et al.
The American Journal of Physiology|December 9, 1998
Liver regeneration is transiently impaired in urokinase-deficient miceH T Roselli, M Su, K Washington, et al.
Pageof 9